Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dogan Fidan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|June 13, 2008
Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trialsJenny Berg, Dogan Fidan, Peter Lindgren
American Journal of Public Health|December 30, 2004
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000Belgin Unal, Julia A Critchley, Dogan Fidan, et al.
BMJ (Clinical Research Ed.)|December 17, 2004
Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective studyA H Miners, Martina Garau, Dogan Fidan, et al.
American Journal of Hematology|July 13, 2007
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolismFrederick A Anderson, Maxim Zayaruzny, John A Heit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 2, 2008
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010Kathleen Bennett, Zubair Kabir, Michael Barry, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2009
The risk of cardiovascular events in primary care patients following an episode of severe hypertensionEdward Ewen, Zugui Zhang, Paul Kolm, et al.
The Cochrane Database of Systematic Reviews|June 10, 2017
WITHDRAWN: Celecoxib for rheumatoid arthritisSarah E Garner, Dogan Fidan, Ruth R Frankish, et al.
Journal of Interventional Cardiology|March 21, 2009
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary interventionEdward F Ewen, Liping Zhao, Paul Kolm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 11, 2008
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillationAnna Ringborg, Robby Nieuwlaat, Peter Lindgren, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|June 13, 2008
Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trialsJenny Berg, Dogan Fidan, Peter Lindgren
American Journal of Public Health|December 30, 2004
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000Belgin Unal, Julia A Critchley, Dogan Fidan, et al.
BMJ (Clinical Research Ed.)|December 17, 2004
Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective studyA H Miners, Martina Garau, Dogan Fidan, et al.
American Journal of Hematology|July 13, 2007
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolismFrederick A Anderson, Maxim Zayaruzny, John A Heit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 2, 2008
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010Kathleen Bennett, Zubair Kabir, Michael Barry, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2009
The risk of cardiovascular events in primary care patients following an episode of severe hypertensionEdward Ewen, Zugui Zhang, Paul Kolm, et al.
The Cochrane Database of Systematic Reviews|June 10, 2017
WITHDRAWN: Celecoxib for rheumatoid arthritisSarah E Garner, Dogan Fidan, Ruth R Frankish, et al.
Journal of Interventional Cardiology|March 21, 2009
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary interventionEdward F Ewen, Liping Zhao, Paul Kolm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 11, 2008
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillationAnna Ringborg, Robby Nieuwlaat, Peter Lindgren, et al.
Pageof 1